1-163328885-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_145697.3(NUF2):āc.315G>Cā(p.Glu105Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000193 in 1,604,436 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_145697.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NUF2 | NM_145697.3 | c.315G>C | p.Glu105Asp | missense_variant | 5/14 | ENST00000271452.8 | NP_663735.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NUF2 | ENST00000271452.8 | c.315G>C | p.Glu105Asp | missense_variant | 5/14 | 1 | NM_145697.3 | ENSP00000271452.3 |
Frequencies
GnomAD3 genomes AF: 0.0000464 AC: 7AN: 150976Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250724Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135530
GnomAD4 exome AF: 0.0000165 AC: 24AN: 1453460Hom.: 1 Cov.: 27 AF XY: 0.0000124 AC XY: 9AN XY: 723630
GnomAD4 genome AF: 0.0000464 AC: 7AN: 150976Hom.: 0 Cov.: 32 AF XY: 0.0000408 AC XY: 3AN XY: 73578
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 10, 2024 | The c.315G>C (p.E105D) alteration is located in exon 5 (coding exon 4) of the NUF2 gene. This alteration results from a G to C substitution at nucleotide position 315, causing the glutamic acid (E) at amino acid position 105 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at